Page last updated: 2024-08-24

telmisartan and Liver Failure

telmisartan has been researched along with Liver Failure in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Mahmood, I	1
Roth, W; Schöndorfer, G; Stangier, J; Su, CA	1

Trials

2 trial(s) available for telmisartan and Liver Failure

Article	Year
Center specificity in the limited sampling model (LSM): can the LSM developed from healthy subjects be extended to disease states? International journal of clinical pharmacology and therapeutics, 2003, Volume: 41, Issue:11 Topics: Antihypertensive Agents; Area Under Curve; Benzimidazoles; Benzoates; Blood Specimen Collection; Computer Simulation; Drug Monitoring; Humans; Hydrochlorothiazide; Liver Failure; Models, Biological; Renal Insufficiency; Telmisartan	2003
Pharmacokinetics and safety of intravenous and oral telmisartan 20 mg and 120 mg in subjects with hepatic impairment compared with healthy volunteers. Journal of clinical pharmacology, 2000, Volume: 40, Issue:12 Pt 1 Topics: Administration, Oral; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Female; Humans; Infusions, Intravenous; Liver; Liver Failure; Male; Middle Aged; Telmisartan	2000

Article

Year

Center specificity in the limited sampling model (LSM): can the LSM developed from healthy subjects be extended to disease states?

International journal of clinical pharmacology and therapeutics, 2003, Volume: 41, Issue:11

Topics: Antihypertensive Agents; Area Under Curve; Benzimidazoles; Benzoates; Blood Specimen Collection; Computer Simulation; Drug Monitoring; Humans; Hydrochlorothiazide; Liver Failure; Models, Biological; Renal Insufficiency; Telmisartan

2003

Pharmacokinetics and safety of intravenous and oral telmisartan 20 mg and 120 mg in subjects with hepatic impairment compared with healthy volunteers.

Journal of clinical pharmacology, 2000, Volume: 40, Issue:12 Pt 1

Topics: Administration, Oral; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Female; Humans; Infusions, Intravenous; Liver; Liver Failure; Male; Middle Aged; Telmisartan

2000